Captrust Financial Advisors Takes $4.77 Million Position in Sotera Health (NASDAQ:SHC)

Captrust Financial Advisors acquired a new stake in Sotera Health (NASDAQ:SHC - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 285,659 shares of the company's stock, valued at approximately $4,771,000. Captrust Financial Advisors owned about 0.10% of Sotera Health as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Wedmont Private Capital raised its holdings in shares of Sotera Health by 6.5% during the third quarter. Wedmont Private Capital now owns 10,915 shares of the company's stock valued at $169,000 after acquiring an additional 664 shares in the last quarter. First Citizens Bank & Trust Co. raised its holdings in Sotera Health by 5.0% in the third quarter. First Citizens Bank & Trust Co. now owns 14,287 shares of the company's stock worth $239,000 after purchasing an additional 677 shares in the last quarter. CWM LLC raised its holdings in Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company's stock worth $25,000 after purchasing an additional 993 shares in the last quarter. GAMMA Investing LLC raised its holdings in Sotera Health by 125.0% in the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company's stock worth $50,000 after purchasing an additional 1,660 shares in the last quarter. Finally, TD Asset Management Inc raised its holdings in Sotera Health by 1.5% in the second quarter. TD Asset Management Inc now owns 123,454 shares of the company's stock worth $1,465,000 after purchasing an additional 1,800 shares in the last quarter. Institutional investors own 91.03% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on SHC shares. Barclays increased their price objective on Sotera Health from $14.00 to $17.00 and gave the stock an "overweight" rating in a report on Tuesday, August 6th. Royal Bank of Canada reiterated an "outperform" rating and issued a $17.00 price objective on shares of Sotera Health in a report on Thursday, November 21st. Finally, Citigroup raised their price target on Sotera Health from $18.00 to $20.00 and gave the company a "buy" rating in a report on Wednesday, November 6th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, Sotera Health has a consensus rating of "Moderate Buy" and an average price target of $16.50.

Sotera Health Stock Up 3.5 %

Shares of NASDAQ:SHC traded up $0.45 on Wednesday, hitting $13.28. 2,508,816 shares of the company traded hands, compared to its average volume of 1,347,183. Sotera Health has a 52 week low of $10.71 and a 52 week high of $17.44. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. The stock has a 50 day simple moving average of $15.10 and a 200-day simple moving average of $14.07. The company has a market cap of $3.76 billion, a PE ratio of 51.32 and a beta of 1.96.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business had revenue of $285.47 million for the quarter, compared to analysts' expectations of $278.64 million. During the same period last year, the business earned $0.18 earnings per share. The company's quarterly revenue was up 8.5% on a year-over-year basis. As a group, research analysts expect that Sotera Health will post 0.61 earnings per share for the current year.

Insider Activity at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm's stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $15.03, for a total value of $150,300,000.00. Following the transaction, the director now directly owns 49,215,301 shares of the company's stock, valued at approximately $739,705,974.03. This trade represents a 16.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 55.12% of the stock is currently owned by insiders.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.